/channels/taxonomy/term/12928/all en /channels/channels/news/stem-cells-and-future-health-care-globe-and-mail-december-8-2021-335460 <p>Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, participated in a <em>Globe and Mail</em> panel on stem cells.</p> <p><a href="https://www.theglobeandmail.com/events/article-stem-cells-and-the-future-of-health-care/"><em>Learn more and watch the recording.</em></a></p> Fri, 10 Dec 2021 00:01:09 +0000 webfull 175448 at /channels /channels/channels/news/how-canadian-researchers-are-using-stem-cell-advances-transform-medicine-globe-and-mail-december-2-335314 <p>Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, is among the experts quoted by <em>The Globe and Mail.</em></p> Fri, 03 Dec 2021 23:55:49 +0000 webfull 175290 at /channels /channels/channels/event/neuro-workshop-human-induced-pluripotent-stem-cell-hipsc-training-course-330013 <p><strong>Apply to register via <a href="http://www.surveymonkey.com/r/3R59C3W">Survey Monkey</a>.</strong></p> <p><strong>Application Deadline: April 15, 2021</strong></p> Thu, 25 Mar 2021 13:30:51 +0000 webfull 169419 at /channels /channels/channels/news/major-european-grant-backs-mcgill-research-rare-condition-328091 <p>The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS). The international team of researchers is coordinated by the Douglas Research Centre and Æ»¹ûÒùԺ’s Associate Professor and Canada Research Chair in Psychiatric Genetics, <a href="https://douglas.research.mcgill.ca/carl-ernst">Carl Ernst.</a> The EJP RD is a joint program between major funding bodies from over 25 countries, including the CIHR and FRQS.</p> Wed, 27 Jan 2021 21:46:58 +0000 webfull 167329 at /channels /channels/channels/news/brain-tumour-awareness-week-290936 <p><strong>Providing excellent care and the latest research to help patients</strong></p> <p>The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.</p> Mon, 22 Oct 2018 20:07:04 +0000 webfull 142360 at /channels /channels/channels/news/mni-forms-promising-open-science-partnership-takeda-283212 <h2>Industry and academia team up for the benefit of people suffering from ALS</h2> <p>A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.</p> <p>The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.</p> Mon, 04 Dec 2017 19:37:18 +0000 webfull 133352 at /channels /channels/news/major-advance-understanding-risky-effective-multiple-sclerosis-treatment-225566 <h4>Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease</h4> Tue, 26 Mar 2013 13:53:15 +0000 webfull 95350 at /channels /channels/news/skin-cells-research-parkinsons-244883 <p>Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.</p> <p> Thu, 02 Apr 2015 19:25:49 +0000 webfull 109239 at /channels /channels/channels/news/mni-researchers-receive-funding-study-arsacs-264344 <p>Two researchers at the Montreal Neurological Institute and Hospital (MNI) of Æ»¹ûÒùÔº have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.</p> Thu, 24 Nov 2016 16:53:44 +0000 webfull 123227 at /channels /channels/channels/news/turning-skin-cells-brain-cells-268068 <h2>Microglia, critical to Alzheimer’s research, can now be produced artificially</h2> <p>The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.</p> Tue, 16 May 2017 14:09:42 +0000 webfull 128253 at /channels